Literature DB >> 1960325

High success rate of atrioventricular node ablation with radiofrequency energy.

J A Yeung-Lai-Wah1, J F Alison, L Lonergan, R Mohama, R Leather, C R Kerr.   

Abstract

Radiofrequency current was introduced as an alternative energy source for transcatheter ablation of cardiac arrhythmias to avoid the complications associated with direct current shocks. Initial use of radiofrequency current for complete ablation of the atrioventricular (AV) node yielded only moderate success rates, presumably because of the small size of electrodes and difficulty in localizing the AV node. The use of a larger 4-mm tip electrode for delivery of radiofrequency current and a method to better localize the AV node were prospectively studied in 32 patients undergoing catheter ablation of the AV node. There were 21 men and 11 women with a mean age of 62 +/- 12 years. Complete AV block was achieved immediately in 31 patients (97%) and it persisted in 28 patients (88%) during a mean follow-up period of 12 +/- 6 months. Three patients who had return of AV condition required no drug therapy for control of ventricular rate during atrial fibrillation. The number of radiofrequency pulses used to achieve complete AV block ranged from 1 to 5 (mean 1.9 +/- 1.1). In greater than 50% of the cases, only one radiofrequency pulse was required. The mean power and duration of radiofrequency pulses were 21.2 +/- 4.5 W and 33 +/- 15 s, respectively. All patients developed a stable junctional escape rhythm within 45 min of successful ablation. The QRS configuration was unchanged in 30 patients. One patient had a new right bundle branch block after ablation. There were no complications related to the ablation procedure.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1960325     DOI: 10.1016/0735-1097(91)90516-c

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  15 in total

Review 1.  Unipolar recording in cardiac electrophysiologic studies.

Authors:  F M Kusumoto
Journal:  J Interv Card Electrophysiol       Date:  1999-07       Impact factor: 1.900

2.  Imaging of adenosine bolus transit following intravenous administration: insights into antiarrhythmic efficacy.

Authors:  G A Ng; W Martin; A C Rankin
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

Review 3.  Endocavitary treatment of atrial fibrillation.

Authors:  S B Olsson; E I Hertervig; O Kongstad; C Meurling; S Yuan
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 4.  Surgery for atrial fibrillation.

Authors:  J M McComb
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 5.  Atrioventricular junction ablation and pacemaker implantation for heart failure associated with atrial fibrillation: potential issues and therapies in the setting of acute heart failure syndrome.

Authors:  Jason C Rubenstein; James A Roth
Journal:  Heart Fail Rev       Date:  2011-09       Impact factor: 4.214

6.  [Ambulatory catheter ablation. Indications, results and risks].

Authors:  K P Kunze; B Hayen; M Geiger
Journal:  Herz       Date:  1998-03       Impact factor: 1.443

Review 7.  Radiofrequency catheter ablation: a new frontier in interventional cardiology.

Authors:  Y Bashir; D E Ward
Journal:  Br Heart J       Date:  1994-02

Review 8.  Role of Atrio-Ventricular Junction Ablation in Symptomatic Atrial Fibrillation for Optimization of Cardiac Resynchronization Therapy.

Authors:  Paul J Garabelli; Stavros Stavrakis
Journal:  J Atr Fibrillation       Date:  2013-04-06

9.  Slow pathway modification for atrioventricular node re-entrant tachycardia: fast junctional tachycardia predicts adverse prognosis.

Authors:  K J Lipscomb; A M Zaidi; A P Fitzpatrick; D Lefroy
Journal:  Heart       Date:  2001-01       Impact factor: 5.994

10.  The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.

Authors:  G N Kay; K A Ellenbogen; M Giudici; M M Redfield; L S Jenkins; M Mianulli; B Wilkoff
Journal:  J Interv Card Electrophysiol       Date:  1998-06       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.